Changes	changes	O	O	O	O
in	in	O	O	O	O
heart	heart	O	O	O	O
size	size	O	O	O	O
during	during	O	O	O	O
long-term	long-term	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
after	after	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
effect	effect	O	O	O	O
of	of	O	O	O	O
long-term	long-term	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
treatment	treatment	O	O	O	O
on	on	O	O	O	O
heart	heart	O	O	O	O
size	size	O	O	O	O
after	after	O	O	O	O
myocardial	myocardial	O	DISEASE	OTHERS	I
infarction	infarction	O	DISEASE	OTHERS	I
was	was	O	O	O	O
evaluated	evaluated	O	O	O	O
by	by	O	O	O	O
X-ray	x-ray	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
double-blind	double-blind	O	O	O	O
study	study	O	O	O	O
including	including	O	O	O	O
241	241	O	O	O	O
patients	patients	O	O	O	O
(	(	O	O	O	O
placebo	placebo	O	O	O	O
126	126	O	O	O	O
,	,	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
115	115	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
follow-up	follow-up	O	O	O	O
period	period	O	O	O	O
was	was	O	O	O	O
12	12	O	O	O	O
months	months	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
timolol-treated	timolol-treated	O	O	O	O
patients	patients	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
small	small	O	O	O	O
but	but	O	O	O	O
significant	significant	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
heart	heart	O	O	O	O
size	size	O	O	O	O
from	from	O	O	O	O
baseline	baseline	O	O	O	O
in	in	O	O	O	O
contrast	contrast	O	O	OTHERS	I
to	to	O	O	O	O
a	a	O	O	O	O
decrease	decrease	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
placebo	placebo	O	O	O	O
group	group	O	O	O	O
.	.	O	O	O	O

These	these	O	O	O	O
differences	differences	O	O	O	O
may	may	O	O	O	O
be	be	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
timolol-induced	timolol-induced	O	O	O	O
bradycardia	bradycardia	O	DISEASE	OTHERS	I
and	and	O	O	O	O
a	a	O	O	O	O
compensatory	compensatory	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
end-diastolic	end-diastolic	O	O	O	O
volume	volume	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
timolol-related	timolol-related	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
heart	heart	O	O	O	O
size	size	O	O	O	O
was	was	O	O	O	O
observed	observed	O	O	O	O
only	only	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
normal	normal	O	O	O	O
and	and	O	O	O	O
borderline	borderline	O	O	O	O
heart	heart	O	O	O	O
size	size	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
cardiomegaly	cardiomegaly	O	O	OTHERS	I
,	,	O	O	O	O
the	the	O	O	O	O
increase	increase	O	O	O	O
in	in	O	O	O	O
heart	heart	O	O	O	O
size	size	O	O	O	O
was	was	O	O	O	O
similar	similar	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
groups	groups	O	O	O	O
.	.	O	O	O	O

After	after	O	O	O	O
re-infarction	re-infarction	O	O	O	O
,	,	O	O	O	O
heart	heart	O	O	O	O
size	size	O	O	O	O
increased	increased	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
placebo	placebo	O	O	O	O
group	group	O	O	O	O
and	and	O	O	O	O
remained	remained	O	O	O	O
unchanged	unchanged	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
timolol	timolol	CHEMICALS	O	OTHERS	I
group	group	O	O	O	O
.	.	O	O	O	O

